Top stories

View all news

22 September 2021

DFC and Citi Risk Management Solution Helps Gavi Strengthen the Foundations of the COVAX Facility

U.S. International Development Finance Corporation, in conjunction with Citi, launch risk management solution for COVAX Facility.

20 September 2021

Iceland renews commitment to global equitable access to vaccines: first doses arrive in Côte d’Ivoire

As part of a donation of 125,726 doses to COVAX, the first shipment of 35,700 doses of the AstraZeneca vaccine donated by Iceland has arrived in Côte d’Ivoire.

13 September 2021

Iraq receives first doses donated by Italy through COVAX

As part of its pledge to deliver 15 million doses of COVID-19 vaccines, the first doses donated by Italy have been delivered to Iraq, with more shipping to additional countries in the coming days.

COVAX vaccine roll-out

>301 million COVAX vaccines shipped
OWP
142 participants

As of 22 Sept 2021

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

The COVID-19 vaccine race

Pre-clinical
185vaccines
are being explored in lab experiments and animals
PHASE 1
40 vaccines
are undergoing safety tests in healthy young individuals
Phase 2
35vaccines
are being tested in broader groups of people
Phase 3
34vaccines
are in large international trials to test their impact on COVID-19
IN USE
21vaccines
are currently being offered to the general population
Phase 4
8vaccines
are being monitored in the wider population after being approved

Source: WHO

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

22 September 2021

The Long View: Cholera and the inequitable origins of public health diplomacy

The arrival of cholera on European shores in the 19th Century helped kick off the long path towards modern global health institutions and diplomacy. However, these beginnings were anything but fair.

22 September 2021

The COVID-19 vaccine race

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19, with 21 vaccines now being rolled out in countries worldwide. Here is an at-a-glance overview of those vaccines and…

22 September 2021

Lower-income countries are letting far fewer COVID-19 vaccine doses expire than wealthier nations

Just 0.2% of COVID-19 vaccine doses delivered to lower-income countries through COVAX expired before they could be administered, estimated to be a significantly lower amount than wealthier countries.

Supported countries

Supported Countries

Our impact

Syringe >822 million children immunised
First aid locator >14 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >150 US$ billion in economic benefits for countries (2000–2017)
Children 85% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Like. Follow. Share.

    Subscribe to our newsletter